Fundamental Analysis
50 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2342.3% | +621.5% | 1 / 3 | +7.5% | +2.87 pp | +1.27 pp | +0.1% | 1.02 | 416.69 | 2.181 | +7,5% | 28,6 | +3.436,4% | 416.69 | 7.42 | +5.515,8% |
| Pts | 12 | 12 | 4 | 0 | 8 | 8 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 9.100 (close price on 2026-10-19)EPS (TTM): 21,8
Financial charts
1.Revenue & growth
VND bn2.181Q2/26
1.Revenue & growth
VND bn2.181Q2/26
2.Profit & growth
VND bn28,4Q2/26
3.Profit mix (Penman)
VND bn15,6Q2/26
4.Margins & cost structure
%6.6%Q2/26
5.Returns & cash cycle
% · days-0.6%Q2/26
6.Earnings quality & cash
VND bn-52,7Q2/26
7.Asset structure
VND bn3.030Q2/26
8.Funding & debt health
VND bn · times3.030Q2/26
9.Revenue backlog
VND bn564Q2/26
10.Valuation
times · %707,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %428Q2/26
Adjusted EPS growth, latest quarter
12,4× higher
Average adjusted EPS growth, 3 quarters
218%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
97.8%
Source: vnstockData through Q2/26